[1] Jemal A,Bray F,Center MM,et al. Global cancer statisties[J]. CA Cancer J Clin,2011,61: 69 - 90.
[2] Llovet JM,Burroughs A,Bruix J. Hepatocellular carcinoma[J]. Lancet,2003,362: 1907 - 1917.
[3] Yuen MF,Hou JL,Chutaputti A. Hepatocellular carcinoma in the A- sia pacific region[J]. J Gastroenterol Hepatol,2009,24: 346 - 353.
[4] World Health Organization. International Agency for Research on
Cancer. GLO-BOCAN 2008. ( http: / /globacan. iarc. fr)
[5] Lau WY,Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review[J]. Ann
Surg,2009,249: 20-25.
[6] Sakon M,Nagano H,Nakamori S,et al. Intrahepatic recurrences of
hepatocellular carcinoma after hepatectomy: analysis based on tumor
hemodynamics[J]. Arch Surg,2002,137: 94 - 99.
[7] Lee YK,Kim SU,Kim DY,et al. Prognostic walue of alpha-fetopro- tein and des-gamma-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolizati-
on[J]. BMC Cancer,2013,13: 5.
[8] 叶任高,陆再英. 内科学[M].第6版.北京:人民卫生出版社,2004: 450.
[9] 陈豪,潘坤官,何丽君. 抗癌中药猫人参研究概况[J]. 海峡药学,2 0 1 1 ,2 3 ( 1 2 ) : 9 - 1 1 .
[10]任红艳,方肇勤,梁超,等. 预知子籽对多种肝癌细胞恶性增殖的
抑制作用研究[J]. 辽宁中医杂志,2015,42(3):459-461.
[11] 吴雄志. 肿瘤中医治疗经验及医案精选[M]. 北京: 人民军医出版社,2011: 18 - 20.
[12] 晁旭,赵英永,魏敏慧,等. 土贝母皂苷对人肝癌细胞 HepG2 增殖
及细胞周期的影响[J]. 江苏医药,2012,38(15):1740-1742.
[13] 吴雄志. 消化系统肿瘤( 吴雄志肿瘤治疗医案精选集) [M]. 沈阳: 辽宁科学技术出版社,2016: 145 - 150.